Home » U.S. Targets China, India APIs to Stem Rx Counterfeiting
U.S. Targets China, India APIs to Stem Rx Counterfeiting
March 7, 2006
The U.S. aims to prevent pharmaceutical counterfeiting overseas by working with China and India to prevent the export of raw drug ingredients to Africa, according to high-ranking Commerce Department officials.